The global granulators for pharmaceutical market, by Product Type (Single Pot Granulators, High Sheer Granulators, Fluid Bed Granulators, Rapid Mixer Granulators, Oscillating Granulators and Others), by Application (End Product Manufacturing, Solid Dosage Formulation, API Manufacturing, and Others), By Granulation Mechanism (Dry Granulators, Wet Granulators and Mixed Granulators), By End User (Pharmaceutical Manufacturing Companies, Contract Manufacturing Organizations, Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 5,486.44 million in 2016 and is projected to exhibit a CAGR of 5.40% over the forecast period (2017 – 2025). Granulators for pharmaceutical market is expected to gain significant traction over the forecast period, owing to substantial expansion of pharmaceutical industry and increasing manufacturing of drugs. The contract manufacturing outsourcing is one of the major trends prevailing in the pharmaceutical market that is leading to number of new players entering into drug manufacturing market. For instance, according to a survey conducted by American Pharmaceutical Review 2016, around 61% of pharmaceutical companies involved in the survey outsourced drug manufacture from various companies.
Rapidly developing pharmaceutical industry expected to foster growth of the global granulators for pharmaceutical market
Insufficient production capability of manufacturing site can constrain the rising demand for high volume pharmaceuticals. According to the National Center for Biotechnology Information 2017, high sheer wet granulation and fluid bed drying were identified to be critical unit operations that impact drug dosage formulation. The pharmaceutical giants and establishing new manufacturing facilities as well as expanding the existing ones in terms of upgrading the manufacturing equipment and procedures. For instance, in November 2017, Fresenius Kabi invested more than US$ 100 Mn in expansion of its manufacturing facility at Wilson, North Carolina. The emerging economies in Asia Pacific region are also adopting the similar policies to meet rising demand for drugs and medicines. For instance, in January 2012, Aptar Pharma, a China-based pharmaceutical company inaugurated second manufacturing site in Mumbai for meeting high demand for drugs in the market. Moreover, Piramal Pharma Solutions, an Indian drug manufacturer in October 2017 invested US$ 55 Million for expansion of API manufacturing units in North America and India. According to the International Trade Administration 2016, Japan and India are the top exporters of pharmaceutical drugs among Asia Pacific due to expertise in mass manufacturing and a significant number of drug manufacturers.
Browse 42 Market Data Tables and 26 Figures spread through 224 Pages and in-depth TOC on “Granulators for Pharmaceutical Market”- by Product Type (Single Pot Granulators, High Sheer Granulators, Fluid Bed Granulators, Rapid Mixer Granulators, Oscillating Granulators and Others), by Application (End Product Manufacturing, Solid Dosage Formulation, API Manufacturing, and Others), By Granulation Mechanism (Dry Granulators, Wet Granulators and Mixed Granulators), By End User (Pharmaceutical Manufacturing Companies, Contract Manufacturing Organizations, Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2025.
To know the latest trends and insights prevalent in Granulators for Pharmaceutical Market, click the link below:
The market players are also focusing on enhancing the performance of the granulators. Major players are focused on developing novel and innovative solutions to maintain leading position in the market. For instance, in June 2015, L B Bohle Maschinen introduced BRC 25, a small dry granulator with low maintenance for easy handling, continuous production, and small footprint. Moreover, in 2015, Bosch Packaging Technology introduced a new granulation unit called GranuLean that facilitates a complete and quick granulation procedure of pharmaceutical ingredients in a compact size unit. The market players are adopting direct marketing strategies by participating in various trade fairs, conferences, and others. For instance, in March 2017, Buhler Group displayed and presented its latest innovative AHPE900 granulator at VIV ASIA 2017, as one of its marketing strategy.
Key Takeaways of Granulators for Pharmaceutical Market:
The key players operating in global granulators for pharmaceutical market include Bosch Packaging Technology, Alexanderwerk, GEA Pharma Systems, Frewitt Pharma Machinery, Diosna, Fluid Air, Inc., Romako Pharmatechnik GmbH, and Gebrüder Lödige Maschinenbau GmbH.
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.